Mitochondrial Iron Metabolism and Its Role in Neurodegeneration

被引:153
作者
Horowitz, Maxx P. [1 ,2 ,3 ]
Greenamyre, J. Timothy [1 ,3 ,4 ]
机构
[1] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15260 USA
[2] Univ Pittsburgh, Med Scientist Training Program, Pittsburgh, PA 15260 USA
[3] Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15260 USA
[4] Univ Pittsburgh, Pittsburgh Inst Neurodegenerat Dis, Pittsburgh, PA 15260 USA
关键词
Alzheimer's disease; FBXL5; iron; iron regulatory protein; iron-sulfur cluster; mitochondria; neurodegeneration; Parkinson's disease; AMYLOID PRECURSOR PROTEIN; SULFUR CLUSTER BIOGENESIS; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; SUBSTANTIA-NIGRA; 5'-UNTRANSLATED REGION; TRANSFERRIN RECEPTOR-2; REGULATORY PROTEIN-1; FERRITIN EXPRESSION; IN-VIVO;
D O I
10.3233/JAD-2010-100354
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
In addition to their well-established role in providing the cell with ATP, mitochondria are the source of iron-sulfur clusters (ISCs) and heme - prosthetic groups that are utilized by proteins throughout the cell in various critical processes. The post-transcriptional system that mammalian cells use to regulate intracellular iron homeostasis depends, in part, upon the synthesis of ISCs in mitochondria. Thus, proper mitochondrial function is crucial to cellular iron homeostasis. Many neurodegenerative diseases are marked by mitochondrial impairment, brain iron accumulation, and oxidative stress - pathologies that are interrelated. This review discusses the physiological role that mitochondria play in cellular iron homeostasis and, in so doing, attempts to clarify how mitochondrial dysfunction may initiate and/or contribute to iron dysregulation in the context of neurodegenerative disease. We review what is currently known about the entry of iron into mitochondria, the ways in which iron is utilized therein, and how mitochondria are integrated into the system of iron homeostasis in mammalian cells. Lastly, we turn to recent advances in our understanding of iron dysregulation in two neurodegenerative diseases (Alzheimer's disease and Parkinson's disease), and discuss the use of iron chelation as a potential therapeutic approach to neurodegenerative disease.
引用
收藏
页码:S551 / S568
页数:18
相关论文
共 115 条
[1]   Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Aβ [J].
Adlard, Paul A. ;
Cherny, Robert A. ;
Finkelstein, David I. ;
Gautier, Elisabeth ;
Robb, Elysia ;
Cortes, Mikhalina ;
Volitakis, Irene ;
Liu, Xiang ;
Smith, Jeffrey P. ;
Perez, Keyla ;
Laughton, Katrina ;
Li, Qiao-Xin ;
Charman, Susan A. ;
Nicolazzo, Joseph A. ;
Wilkins, Simon ;
Deleva, Karolina ;
Lynch, Toni ;
Kok, Gaik ;
Ritchie, Craig W. ;
Tanzi, Rudolph E. ;
Cappai, Roberto ;
Masters, Colin L. ;
Barnham, Kevin J. ;
Bush, Ashley I. .
NEURON, 2008, 59 (01) :43-55
[2]   Biosynthesis of heme in mammals [J].
Ajioka, Richard S. ;
Phillips, John D. ;
Kushner, James P. .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2006, 1763 (07) :723-736
[3]   Iron-induced oligomerization of yeast frataxin homologue Yfh1 is dispensable in vivo [J].
Aloria, K ;
Schilke, B ;
Andrew, A ;
Craig, EA .
EMBO REPORTS, 2004, 5 (11) :1096-1101
[4]   Iron Toxicity in Diseases of Aging: Alzheimer's Disease, Parkinson's Disease and Atherosclerosis [J].
Altamura, Sandro ;
Muckenthaler, Martina U. .
JOURNAL OF ALZHEIMERS DISEASE, 2009, 16 (04) :879-895
[5]   Therapeutic targets and potential of the novel brain- permeable multifunctional iron chelator-monoamine oxidase inhibitor drug, M-30, for the treatment of Alzheimer's disease [J].
Avramovich-Tirosh, Yael ;
Amit, Tamar ;
Bar-Am, Orit ;
Zheng, Hailin ;
Fridkin, Mati ;
Youdim, Moussa B. H. .
JOURNAL OF NEUROCHEMISTRY, 2007, 100 (02) :490-502
[6]   Physiological and pathological aspects of Aβ in iron homeostasis via 5′UTR in the APP mRNA and the therapeutic use of iron-chelators [J].
Avramovich-Tirosh, Yael ;
Amit, Tamar ;
Bar-Am, Orit ;
Weinreb, Orly ;
Youdim, Moussa B. H. .
BMC NEUROSCIENCE, 2008, 9 (Suppl 2)
[7]   High-throughput drug screen targeted to the 5′ untranslated region of Alzheimer amyloid precursor protein mRNA [J].
Bandyopadhyay, Sanghamitra ;
Ni, Jake ;
Ruggiero, Amy ;
Walshe, Karen ;
Rogers, Mark S. ;
Chattopadhyay, Naibedya ;
Glicksman, Marcie A. ;
Rogers, Jack T. .
JOURNAL OF BIOMOLECULAR SCREENING, 2006, 11 (05) :469-480
[8]   Neuroprotection by a novel brain permeable iron chelator, VK-28, against 6-hydroxydopamine lession in rats [J].
Ben Shachar, D ;
Kahana, N ;
Kampel, V ;
Warshawsky, A ;
Youdim, MBH .
NEUROPHARMACOLOGY, 2004, 46 (02) :254-263
[9]   In vivo detection of iron and neuromelanin by transcranial sonography - a new approach for early detection of substantia nigra damage [J].
Berg, D. .
JOURNAL OF NEURAL TRANSMISSION, 2006, 113 (06) :775-780
[10]   Disturbance of iron metabolism in Parkinson's disease ultrasonography as a biomarker [J].
Berg, D ;
Hochstrasser, H ;
Schweitzer, KJ ;
Riess, O .
NEUROTOXICITY RESEARCH, 2006, 9 (01) :1-13